menu
    • menu

    Company profile for VBI Vaccines

    NEW Drugs in Dev: 17
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    VBI Vaccines Inc. is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. VBI’s first marketed product is Sci-B-Vac®, a hepatitis B (“HBV”) vaccine that mimics all three viral surface antigens of the hepatitis B virus; Sci-B-Vac is approved for use in Israel and 10 other countries. VBI’s eVLP Platform technology allows ...
    VBI Vaccines Inc. is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. VBI’s first marketed product is Sci-B-Vac®, a hepatitis B (“HBV”) vaccine that mimics all three viral surface antigens of the hepatitis B virus; Sci-B-Vac is approved for use in Israel and 10 other countries. VBI’s eVLP Platform technology allows for the development of enveloped (“e”) virus-like particle (“VLP”) vaccines that closely mimic the target virus to elicit a potent immune response.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VBI VaccinesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    VBI Vaccines Inc. 222 Third Street, Suite 2241 Cambridge, MA 02142
    Telephone
    Telephone
    (617) 830-3031
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vbivaccines.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    VBI recalls hepatitis B shot as it winds down operations
    VBI recalls hepatitis B shot as it winds down operations

    18 Nov 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/vbi-vaccines-pulls-hepatitis-b-vaccine-prehevbrio-shelves-after-filing-bankruptcy

    FIERCE PHARMA
    18 Nov 2024
    Share Share
    VBI Vaccines Issues Voluntary Recall of PreHevbrio Vaccine
    VBI Vaccines Issues Voluntary Recall of PreHevbrio Vaccine

    15 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241115135978/en

    BUSINESSWIRE
    15 Nov 2024
    Share Share
    VBI Vaccines Provides an Update on its Restructuring Proceedings
    VBI Vaccines Provides an Update on its Restructuring Proceedings

    02 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240802116901/en

    BUSINESSWIRE
    02 Aug 2024
    Share Share
    VBI Vaccines secures court protection as it restructures, seeks buyer(s)
    VBI Vaccines secures court protection as it restructures, seeks buyer(s)

    30 Jul 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/vbi-vaccines-secures-court-protection-it-restructures-seeks-buyers

    FIERCE BIOTECH
    30 Jul 2024
    Share Share
    VBI Vaccines Initiates CCAA Restructuring Proceedings
    VBI Vaccines Initiates CCAA Restructuring Proceedings

    30 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240730295745/en

    BUSINESSWIRE
    30 Jul 2024
    Share Share
    VBI Vaccines Announces AGM Results
    VBI Vaccines Announces AGM Results

    25 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240625000048/en

    BUSINESSWIRE
    25 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search